vimarsana.com

Latest Breaking News On - The vaccine - Page 1 : vimarsana.com

Musk shares post that misleads on Covid-19 vaccine efficacy

A video shared by Elon Musk stitches together screenshots of headlines that appeared to show declining estimates of protection from Covid-19 vaccines. The clip is missing context; the headlines are presented out of order, using incomparable data, and while the jabs do not completely protect against infection, physicians and epidemiologists say they are effective in reducing the risk of severe illness and death.

Second Malaria Vaccine Gets WHO Approval: 5 Things To Know

Around 1 8 million Americans received COVID shots last week-IQVIA

(Reuters) -Around 1.8 million people in the U.S. received a COVID-19 vaccine during the week ended Sept. 22, according to data compiled by health care data and analytics firm IQVIA Holdings Inc. Around 1 million people received the Pfizer/BioNTech shot and just under 800,000 got the Moderna vaccine, Michael Kleinrock, senior research director at the IQVIA institute told Reuters on Friday. "It feels like a good number," Kleinrock said, noting that over the past two years, the public health emergency and vaccine mandates were helping to drive demand.

As COVID Infections Rise, Nursing Homes Are Still Waiting for Vaccines

“COVID is not pretty in a nursing home,” said Deb Wityk, a 70-year-old retired massage therapist who lives in one called Spurgeon Manor, in rural Iowa. She has contracted the disease twice and is eager to get the newly approved vaccine because she has chronic leukemia, which weakens her immune system. The Centers for Disease Control and Prevention approved the latest vaccine two weeks ago, and the new shots became available to the general public within the last week or so. But many nursing homes

Health Canada approves Moderna s updated COVID-19 vaccine

Health Canada has approved Moderna's updated COVID-19 vaccine for all Canadians who are six months of age and older — while two other options for fall shots remain in the regulatory pipeline.Federal officials announced the approval on Tuesday morning, more than two months after Moderna submitted its new formulation. The mRNA-based shot is monovalent, targeting just the Omicron XBB.1.5 subvariant, which means the vaccine is more tailored to the virus strains currently circulating."I know we all w

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.